Tirzepatide
Dual Receptor Agonist
Tirzepatide (Dual Receptor Agonist) is a research-grade peptide supplied by Living Water Labs for laboratory investigation. Dual GIP/GLP-1 receptor metabolic optimisation. Each batch is HPLC-verified to a minimum 98% purity with a batch-specific Certificate of Analysis. The summary below outlines documented mechanisms and study areas reported in the research literature.
Scientific name
LY3298176 (GIP/GLP-1 Receptor Dual Agonist)
Molecular weight
4813.5 g/mol
Purity
99.1%
Vial size
10mg
DOCUMENTED RESEARCH AREAS
- ▸Dual incretin receptor activity (GIP, GLP-1) studied in metabolic-pathway research
- ▸Body-weight and metabolic endpoints evaluated in clinical research trials
- ▸Insulin-secretion and glucose-metabolism pathways studied in preclinical models
- ▸Gastric-emptying and satiety signalling studied in research models
- ▸Hepatic lipid-accumulation markers studied in metabolic research models
- ▸Acts on hypothalamic and gut-brain-axis satiety signalling in research models
- ▸Lean-mass markers studied relative to body-composition endpoints
CITED LITERATURE (PUBMED)
All information is provided for research and educational purposes only and describes findings in preclinical/in-vitro literature. Not medical advice. Products are supplied strictly for research purposes — not for human or animal consumption.